← Open Payments lookup

ALISON PERRYMAN: Open Payments

NPI 1124627690 · HERNANDO, MS. Company-reported industry payments from CMS Open Payments. A payment does not imply wrongdoing.

See the full provider profile for registry, prescribing and billing details.

Industry payments (Sunshine Act)

Source: CMS Open Payments general payments. Payments from drug and device companies are reported by the companies; they do not imply wrongdoing and are separate from Medicare billing.

$1,611 in 93 payments from 11 companies in 2025. Trend: 2023 $1,139 · 2024 $1,386 · 2025 $1,611

Food & beverage: $1,598Education: $12
CompanyPaymentsAmount
ITI, Inc. (d/b/a Intra-Cellular Therapies, Inc.)21$491
Collegium Pharmaceutical, Inc.18$232
Neurocrine BioSciences, Inc.14$230
ABBVIE INC.19$214
Supernus Pharmaceuticals, Inc.8$136
Axsome Therapeutics, Inc.4$102
Takeda Pharmaceuticals U.S.A., Inc.4$84
Otsuka America Pharmaceutical, Inc.2$47
Lundbeck LLC1$32
E.R. Squibb & Sons, L.L.C.1$28

Products named: CAPLYTA, Jornay PM, INGREZZA, VRAYLAR, Qelbree, Auvelity, TRINTELLIX, REXULTI.

Industry payments across MS — which companies pay providers there.